Cellectar Biosciences, Inc.

NasdaqCM:CLRB Stock Report

Market Cap: US$11.7m

Cellectar Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CLRB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Dec 25SellUS$732John NeisIndividual198US$3.70
02 Jul 25BuyUS$24,950Chad KoleanIndividual5,000US$4.99
02 Jul 25BuyUS$49,900Jarrod LongcorIndividual10,000US$4.99
02 Jul 25BuyUS$49,900James CarusoIndividual10,000US$4.99

Insider Trading Volume

Insider Buying: CLRB insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLRB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders155,9823.68%
Institutions514,78212.1%
General Public3,569,37084.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 208.2%.

Top Shareholders

Top 25 shareholders own 15.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.72%
Bleichroeder LP
200,000US$554.0k100%0.09%
2.95%
Brendan O’Neil
125,000US$346.3k-16.7%no data
2.1%
The Vanguard Group, Inc.
89,120US$246.9k36.8%no data
1.51%
Intracoastal Capital LLC
63,872US$176.9k572%1.98%
1.07%
DRW Holdings, LLC
45,190US$125.2k114%0.01%
0.68%
Geode Capital Management, LLC
28,636US$79.3k15%no data
0.6%
Sequoia Financial Advisors, LLC
25,350US$70.2k135%no data
0.33%
Warberg Asset Management LLC
13,900US$38.5k0%0.12%
0.3%
Jarrod Longcor
12,768US$35.4k0%no data
0.29%
XTX Markets Limited
12,243US$33.9k0%no data
0.29%
Susquehanna International Group, LLP
12,204US$33.8k0%no data
0.27%
James Caruso
11,638US$32.2k0%no data
0.24%
Riverview Capital Advisers, LLC
10,384US$28.8k0%0.01%
0.15%
Chad Kolean
6,418US$17.8k0%no data
0.11%
BlackRock, Inc.
4,745US$13.1k0%no data
0.061%
UBS Asset Management AG
2,598US$7.2k186%no data
0.06%
ADAR1 Capital Management, LLC
2,540US$7.0k0%no data
0.043%
Tower Research Capital Europe Limited
1,833US$5.1k68.2%no data
0.026%
Nantahala Capital Management, LLC
1,109US$3.1k0%no data
0.012%
Morgan Stanley
510US$1.4k0%no data
0.01%
Spearhead Insurance Solutions Idf, Llc
422US$1.2k0%0.01%
0.002%
Douglas Swirsky
83US$230.20%no data
0.0015%
Frederick Driscoll
65US$179.70%no data
0.0015%
The Toronto-Dominion Bank
63US$175.00%no data
0.00085%
Bank of America Corporation
36US$99.833.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/06 22:43
End of Day Share Price 2026/03/06 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cellectar Biosciences, Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Keith MarkeyGriffin Securities
Aydin HuseynovLadenburg Thalmann & Company